Have questions? Visit https://www.reddit.com/r/SNPedia

rs1801159

From SNPedia

Orientationminus
Stabilizedminus
Geno Mag Summary
(A;A) 0 common in clinvar
(T;T) 0
Make rs1801159(A;G)
Make rs1801159(G;G)
ReferenceGRCh38 38.1/141
Chromosome1
Position97515839
GeneDPYD
is asnp
is mentioned by
dbSNPrs1801159
dbSNP (classic)rs1801159
ClinGenrs1801159
ebirs1801159
HLIrs1801159
Exacrs1801159
Gnomadrs1801159
Varsomers1801159
LitVarrs1801159
Maprs1801159
PheGenIrs1801159
Biobankrs1801159
1000 genomesrs1801159
hgdprs1801159
ensemblrs1801159
geneviewrs1801159
scholarrs1801159
googlers1801159
pharmgkbrs1801159
gwascentralrs1801159
openSNPrs1801159
23andMers1801159
SNPshotrs1801159
SNPdbers1801159
MSV3drs1801159
GWAS Ctlgrs1801159
GMAF0.2048
Max Magnitude0
? (A;A) (A;G) (G;G) 28



[PMID 19104657OA-icon.png] Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.


[PMID 21362212] [Detection of single nucleotide polymorphisms of mthfr and dpyd genes in leukemia cell lines K562 and K562/A02].


[PMID 25027354OA-icon.png] [Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines].


[PMID 23988873OA-icon.png] [Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing].


[PMID 23942539] [Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients].


ClinVar
Risk rs1801159(G;G)
Alt rs1801159(G;G)
Reference Rs1801159(A;A)
Significance Probable-non-pathogenic
Disease not provided not specified Dihydropyrimidine dehydrogenase deficiency
Variation info
Gene DPYD
CLNDBN not provided not specified Dihydropyrimidine dehydrogenase deficiency
Reversed 1
HGVS NC_000001.10:g.97981395T>C
CLNSRC UniProtKB (protein)
CLNACC RCV000086475.1, RCV000174446.2, RCV000389596.1,



[PMID 29372689] DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia.